Skip to search formSkip to main contentSkip to account menu

BIBR 1532

Known as: BIBR-1532, BIBR1532 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

AminobenzoatesNaphthalenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Erratum to: A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines
A funding statement was omitted from the original publication of this article. Page 572: The Acknowledgements, which previously… 
2014
2014
Evaluation Of BIBR1532 And ATRA Combination In NB4 Cell Line
Background and Aim: Acute promyelocytic leukemia (APL) is a distinct type of leukemia which is caused due to a blockage in… 
2013
2013
Effect of Telomerase Inhibitors on Malignant Breast Cancer Cells
Current therapies have nominal effect on the most intrusive-type of breast cancers (triplenegative) that have a higher tendency… 
2013
2013
Cancer Cell Death Inhibition of Telomerase Recruitment and DNA and Chromosomes
2011
2011
[The influence of compound aITEL1296 on telomerase activity and the growth of cancer cells].
Telomerase is a ribonucleoprotein that synthesizes telomeric repeats and identified as a promising target for anticancer therapy… 
Review
2010
Review
2010
IPM Reduces Pesticides , Cockroaches , and Asthma
Cockroaches are major structural pests and are an ongoing part of urban life. Because of their contact with sewers and unsanitary… 
2010
2010
Abstract 3334: Telomerase activity corresponds to the level of aggressiveness of ovarian cancer stem cells and are a potential site of targeted therapy
Objective: Cancer stem cells possess the important property of self-renewal. Telomerase activity (TA) is often used as a… 
2006
2006
Characterization of Bcr-Abl Positive Leukemic Cells under Long-Term In Vitro Treatment with Telomerase Inhibitor BIBR1532.
In normal somatic cells telomeres shorten with each cell division because of the end-replication problem. The ribonucleoprotein… 
2005
2005
The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line.
Telomerase is the ribonucleoprotein enzyme that maintains telomeres of eukaryotic chromosomes. Activation of telomerase is a… 
2004
2004
Candidate drug BIBR1532 induces telomere shortening and growth inhibition in lymphoid cell lines.
6605 Background: Telomerase inhibition is a new strategy that might be useful in inducing senescence and growth inhibition (GI… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)